Predictive biomarkers of breast ductal carcinoma in situ may underestimate the risk of recurrence due to de novo ipsilateral breast carcinoma development

Tools

Item Type:	Preprint
Title:	Predictive biomarkers of breast ductal carcinoma in situ may underestimate the risk of recurrence due to de novo ipsilateral breast carcinoma development
Creators Name:	Kader, T., Zethoven, M., Mahale, S., Saunders, H., Tjoeka, L., Lehmann, R., Jayawardane, M., Pang, J.M., Lesche, D., Rajan, N., Semple, T., Lee, J.E.A., Lupat, R., Byrne, D.J., Hughes, S., Nguyen, H., Lai, S., Pechlivanis, M., Craig, O., Devereux, L., House, E., Jayasinghe, S.I., Kaufmann, T.L., Schwarz, R.F., Green, A.R., Miligy, I., Cummings, M., Lakhani, S., Campbell, I.G., Rakha, E., Fox, S.B., Mann, G.B. and Gorringe, K.L.
Abstract:	Development of ipsilateral breast carcinoma following diagnosis of breast ductal carcinoma in situ (DCIS) has been assumed to represent recurrence of the primary tumour. However, this may not be the case and it is important to know how often recurrences are new tumours. Ipsilateral primary-recurrence pairs (n=78) were sequenced to test their clonal relatedness. Shared genetic events were identified from whole exome sequencing (n=54 pairs) using haplotype-specific copy number and phylogenetic analysis. The remaining pairs were sequenced by a targeted panel or low-coverage whole genome sequencing. We included 32 non-recurrent DCIS to compare recurrent and non-recurrent disease. We found that 7% of DCIS recurrences were non-clonal by whole exome sequencing, indicative of a new breast carcinoma. Lower resolution methods detected a higher non-clonality rate (29%). Comparing primary DCIS with their recurrences found that evolution of DCIS to invasive disease was associated with increased ploidy and copy number events. TP53 mutations were enriched in DCIS with clonal recurrence compared with non-recurrent DCIS. Our results verify that de novo “recurrent tumours” of independent origin occur in patients who may be at high risk.
Keywords:	Ductal Carcinoma In Situ, Recurrence, Clonality, Breast Neoplasm, Whole Exome Sequencing, Phylogenetic Analysis
Source:	bioRxiv
Publisher:	Cold Spring Harbor Laboratory Press
Article Number:	2024.05.19.594731v2
Date:	15 July 2025
Official Publication:	https://doi.org/10.1101/2024.05.19.594731

Repository Staff Only: item control page